Optimal treatment of hypertension in the elderly: A Korean perspective

Geriatrics and Gerontology International

Volumn 8, Issue 1, 2008, Pages 5-11

  Kim, Kwang Il ^a   Cho, Young Seok ^a   Choi, Dong Ju ^a   Kim, Cheol Ho ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Cardiovascular disease; Elderly; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; AGING; BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; KOREA; MALE; PHYSIOLOGY; REVIEW;

AGED; AGING; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; KOREA; MALE;

EID: 55249083380     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2008.00440.x     Document Type: Review

References (54)

1. Lakatta EG, Levy D. Arterial and cardiac aging: Major shareholders in caAdiovascAlar disease enterprises: Part I: aging arteries: a 'set up' for vascular disease. Circulation 2003; 107: 139-146.
2. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: Is it an immutable cardiovascular risk factor? Hypertension 2005; 46: 454-462.
3. Vasan RS, Beiser A, Seshadri S etal. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287: 1003-1010.
4. Elliott WJ. Management of hypertension in the very elderly patient. Hypertension 2004; 44: 800-804.
5. O'Rourke MF, Adji A. An updated clinical primer on large artery mechanics: Implications of pulse waveform analysis and arterial tonometry. Curr Opin Cardiol 2005; 20: 275-281.
6. Dart AM, Kingwell BA. Pulse pressure - a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001; 37: 975-984.
7. Mitchell GF, Parise H, Benjamin EJ et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: The Framingham Heart Study. Hypertension 2004; 43: 1239-1245.
8. Laurent S, Katsahian S, Fassot C et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003; 34: 1203-1206.
9. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107: 2864-2869.
10. Sutton-Tyrrell K, Najjar SS, Boudreau RM et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005; 111: 3384-3390.
11. Lakatta EG. Arterial and cardiac aging: Major shareholders in cardCovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003; 107: 490-497.
12. Safar ME, Boudier HS. Vascular development, pulse pressure, and the mechanisms of hypertension. Hypertension 2005; 46: 205-209.
13. Kass DA. Ventricular arterial stiffening: Integrating the pathophysiology. Hypertension 2005; 46: 185-193.
14. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 932-943.
15. Kass DA, Shapiro EP, Kawaguchi M et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001; 104: 1464-1470.
16. Bakris GL, Bank AJ, Kass DA, Neutel JM, Preston RA, Oparil S. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens 2004; 17: 23S-30S.
17. Vaitkevicius PV, Lane M, Spurgeon H et al. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci USA 2001; 98: 1171-1175.
18. Amery A, Birkenhager W, Brixko R et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet 1986; 2: 589-592.
19. Rastas S, Pirttila T, Viramo P et al. Association between blood pressure and survival over 9 years in a general population aged 85 and older. J Am Geriatr Soc 2006; 54: 912-918.
20. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
21. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: Principal results. BMJ 1992; 304: 405-412.
22. Staessen JA, Fagard R, Thijs L et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-764.
23. Wang JG, Staessen JA, Gong L, Liu L. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group. Arch Intern Med 2000; 160: 211-220.
24. Chaudhry SI, Krumholz HM, Foody JM. Systolic hypertension in older persons. JAMA 2004; 292: 1074-1080.
25. National Intervention Cooperative Study in Elderly Hypertensives Study Group. Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. Hypertension 1999; 34: 1129-1133.
26. Bulpitt CJ, Beckett NS, Cooke J et al. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 2003; 21: 2409-2417.
27. Bulpitt CJ, Peters R, Staessen JA et al. Fracture risk and the use of a diuretic (indapamide sr) +/- perindopril: A substudy of the Hypertension in the Very Elderly Trial (HYVET). Trials 2006; 7: 33.
28. Peters R, Beckett N, Nunes M, Fletcher A, Forette F, Bulpitt C. A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG): An ongoing randomised, double-blind, placebo-controlled trial. Drugs Aging 2006; 23: 83-92.
29. Japanese Society of Hypertension. Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Hypertens Res 2006; 29(Suppl): S1-S105.
30. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572.
31. JATOS Study Group. The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): Protocol, patient characteristics, and blood pressure during the first 12 months. Hypertens Res 2005; 28: 513-520.
32. Thomson R, Greenaway J, Chinn DJ, Wood R, Rodgers H. The impact of implementing national hypertension guidelines on prevalence and workload in primary care: A population-based survey of older people. J Hum Hypertens 2005; 19: 683-689.
33. Dahlof B, Sever PS, Poulter NR et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet 2005; 366: 895-906.
34. Wing LM, Reid CM, Ryan P et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348: 583-592.
35. Fournier A, Messerli FH, Achard JM, Fernandez L. Cerebroprotection mediated by angiotensin II: A hypothesis supported by recent randomized clinical trials. J Am Coll Cardiol 2004; 43: 1343-1347.
36. Ogihara T. Practitioner's Trial on the Efficacy of Antihypertensive Treatment in the Elderly Hypertension (The PATE-Hypertension Study) in Japan. Am J Hypertens 2000; 13: 461-467.
37. Ogihara T, Rakugi H. Hypertension in the elderly: A Japanese perspective. Drugs Aging 2005; 22: 297-314.
38. Staessen JA, Richart T, Birkenhager WH. Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension 2007; 49: 389-400.
39. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005; 4: 487-499.
40. Kuo HK, Lipsitz LA. Cerebral white matter changes and geriatric syndromes: Is there a link? J Gerontol A Biol Sci Med Sci 2004; 59: 818-826.
41. Forette F, Seux ML, Staessen JA et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 1347-1351.
42. Lithell H, Hansson L, Skoog I et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21: 875-886.
43. den Heijer T, Launer LJ, Prins ND et al. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology 2005; 64: 263-267.
44. Eto M, Toba K, Akishita M et al. Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension. Hypertens Res 2005; 28: 1-7.
45. Bjorklund K, Lind L, Zethelius B, Berglund L, Lithell H. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens 2004; 22: 1691-1697.
46. Mancia G, Parati G. The role of blood pressure variability in end-organ damage. J Hypertens Suppl 2003; 21: S17-S23.
47. Sega R, Corrao G, Bombelli M et al. Blood pressure variability and organ damage in a general population: Results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 2002; 39: 710-714.
48. Parati G, Mancia G. Blood pressure variability as a risk factor. Blood Press Monit 2001; 6: 341-347.
49. Gunstad J, Cohen RA, Tate DF et al. Blood pressure variability and white matter hyperintensities in older adults with cardiovascular disease. Blood Press 2005; 14: 353-358.
50. Gomez-Angelats E, de La Sierra A, Sierra C, Parati G, Mancia G, Coca A. Blood pressure variability and silent cerebral damage in essential hypertension. Am J Hypertens 2004; 17: 696-700.
51. Pringle E, Phillips C, Thijs L et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003; 21: 2251-2257.
52. Kario K, Pickering TG. Blood pressure variability in elderly patients. Lancet 2000; 355: 1645-1646.
53. Emberson J, Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J 2004; 25: 484-491.
54. Kim JA, Kim SM, Choi YS et al. The prevalence and risk factors associated with isolated untreated systolic hypertension in Korea: The Korean National Health and Nutrition Survey 2001. J Hum Hypertens 2007; 21: 107-113.